BRCA2 and cancer: EEF1A1 mRNA expression was associated with increased sensitivity to olaparib in the GDSC pan-cancer cell lines and found to be highly expressed in olaparib-sensitive HGSOC cell lines, including BRCA2-mutated cell line OV4453, compared to resistant cell lines (Figure 5B).